Home » Newsletters » BioWorld

BioWorld

June 15, 1993

View Archived Issues

RAC APPROVALS REFLECT GROWTH IN GENE THERAPY

VIRAGEN GETS $1M FROM INVESTMENT COMPANY

BECTON INVESTS $5M IN NEXAGEN

ANTISENSE STRATEGY TO PREVENT HAIR LOSS

IMMULOGIC, MERCK TO CONCLUDE PACT

IVAX TO ACQUIRE JOHNSON PRODUCTS

DIABETIC DOGS THRIVE WITH ISLET TRANSPLANTS

LEAD CANCER TARGET OCCURS OFTEN

ALLERGY ANSWERS DIFFICULT TO COME BY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...